Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1999 Jul;90(7):794–800. doi: 10.1111/j.1349-7006.1999.tb00817.x

Antitumor Effect on Human Gastric Cancer and Induction of Apoptosis by Vascular Endothelial Growth Factor Neutralizing Antibody

Kinji Kamiya 1, Hiroyuki Konno 1,✉, Tatsuo Tanaka 1, Megumi Baba 1, Keigo Matsumoto 1, Takanori Sakaguchi 1, Ayako Yukita 2, Makoto Asano 2, Hideo Suzuki 2, Tomio Arai 3, Satoshi Nakamura 1
PMCID: PMC5926128  PMID: 10470294

Abstract

Induction of apoptosis by antiangiogenic therapy has been suggested as a new anticancer strategy. To clarify the mechanism of the antitumor effect achieved by inhibition of vascular endothelial growth factor (VEGF), which is a major mediator of angiogenesis, we used an orthotopic transplantation model of human gastric carcinoma line (MT2) treated with a monoclonal VEGF neutralizing antibody (VEGF Ab). We histologically examined the microvessel density (MVD) and the apoptotic index (AI) in this model. Transplanted tumor growth was significantly inhibited by the VEGF Ab (P= 0.03), and there was a significant decrease in the number of mice with liver metastasis (P= 0.004). The MVD detected by immunohistochemical staining with ER‐MP12 antibody was 33.6 ± 8.0 in the control group and 21.1 ± 5.4 in the treated group, and the difference was significant (P < 0.0001). The AI values of the control and treated groups were 4.73 ± 1.11 and 7.26 ± 1.62, respectively, and this difference is also significant (P < 0.0001). However, the expression of VEGF mRNA in transplanted tumors did not show a significant difference between the control and treated groups. These results suggest that the antitumor effect of the VEGF Ab on human gastric carcinoma is exerted by inducing mild hypoxia followed by apoptosis, which does not influence VEGF mRNA expression in the carcinoma.

Keywords: Antiangiogenic therapy, Apoptosis, Vascular endothelial growth factor, Microvessel density

Full Text

The Full Text of this article is available as a PDF (3.4 MB).

REFERENCES

  • 1).Arai , T. and Kino , I.Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas . J. Pathol. , 176 , 37 – 44 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 2).Kerr , J. F. , Winterford , C. M. and Harmon , B. V.Apoptosis. Its significance in cancer and cancer therapy . Cancer , 73 , 2013 – 2026 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 3).Sen , S. and D'Incalci , M.Apoptosis. Biochemical events and relevance to cancer chemotherapy . FEBS Lett. , 307 , 122 – 127 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 4).Fisher , D. E.Apoptosis in cancer therapy: crossing the threshold . Cell , 78 , 539 – 542 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 5).Holmgren , L. , O'Reilly , M. S. and Folkman , J.Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression . Nat. Med. , 1 , 149 – 153 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 6).O'Reilly , M. S. , Holmgren , L. , Chen , C. and Folkman , J.Angiostatin induces and sustains dormancy of human primary tumors in mice . Nat. Med. , 2 , 689 – 692 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 7).O'Reilly , M. S. , Boehm , T. , Shing , Y. , Fukai , N. , Vasios , G. , Lane , W. S. , Flynn , E. , Birkhead , J. R. , Olsen , B. R. and Folkman , J.Endostatin: an endogenous inhibitor of angiogenesis and tumor growth . Cell , 88 , 277 – 285 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 8).Ahmed , M. H. , Konno , H. , Nahar , L. , Tanaka , T. , Naito , Y. , Nakamura , S. and Baba , S.The angiogenesis inhibitor TNP‐470 (AGM‐1470) improves long‐term survival of rats with liver metastasis . J. Surg. Res. , 64 , 35 – 41 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 9).Ahmed , M. H. , Arai , T. , Konno , H. , Nahar , L. , Tanaka , T. , Izumiyama , N. , Takubo , K. , Nakamura , S. and Baba , S.Regression of metastatic liver tumors in rats treated with angiogenesis inhibitor TNP‐470: occurrence of apoptosis and necrosis . Jpn. J. Cancer Res. , 88 , 977 – 981 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10).Folkman , J. and Klagsburn , M.Angiogenic factors . Science , 235 , 442 – 447 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 11).Ferrara , N. and Davis‐Smyth , T.The biology of vascular endothelial growth factor . Endocr. Rev. , 18 , 4 – 25 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 12).Maeda , K. , Chung , Y. S. , Ogawa , Y. , Takatsuka , S. , Kang , S. M. , Ogawa , M. , Sawada , T. and Sowa , M.Prognostic value of vascular endothelial growth factor expression in gastric carcinoma . Cancer , 77 , 858 – 863 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 13).Gasparini , G. , Toi , M. , Gion , M. , Verderio , P. , Dittadi , R. , Hanatani , M. , Matsubara , I. , Vinante , O. , Bonoldi , E. , Boracchi , P. , Gatti , C. , Suzuki , H. and Tominaga , T.Prognostic significance of vascular endothelial growth factor protein in node‐negative breast carcinoma . J. Natl. Cancer Inst. , 89 , 139 – 147 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 14).Kim , K. J. , Li , B. , Houck , K. , Winer , J. and Ferrara , N.The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies . Growth Factors , 7 , 53 – 64 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 15).Kim , K. J. , Li , B. , Winer , J. , Armanini , M. , Gillett , N. , Phillips , H. S. and Ferrara , N.Inhibition of vascular endothelial growth factor‐induced angiogenesis suppresses tumour growth in vivo . Nature , 362 , 841 – 844 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 16).Warren , R. S. , Yuan , H. , Matli , M. R. , Gillett , N. A. and Ferrara , N.Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis . J. Clin. Invest. , 95 , 1789 – 1797 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17).Asano , M. , Yukita , A. , Matsumoto , T. , Hanatani , M. and Suzuki , H.An anti‐human VEGF monoclonal antibody, MV833, that exhibits potent anti‐tumor activity in vivo . Hybridoma , 17 , 185 – 190 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 18).Kanai , T. , Konno , H. , Tanaka , T. , Baba , M. , Matsumoto , K. , Nakamura , S. , Yukita , A. , Asano , M. , Suzuki , H. and Baba , S.Anti‐tumor and anti‐metastatic effects of human vascular‐endothelial‐growth‐factor‐neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice . Int. J. Cancer , 77 , 933 – 936 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 19).Kanai , T. , Konno , H. , Tanaka , T. , Matsumoto , K. , Baba , M. , Nakamura , S. and Baba , S.Effect of angiogenesis inhibitor TNP‐470 on the progression of human gastric cancer xenotransplanted into nude mice . Int. J. Cancer , 71 , 838 – 841 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 20).Furukawa , T. , Fu , X. , Kubota , T. , Watanabe , M. , Kitajima , M. and Hoffman , R. M.Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue . Cancer Res. , 53 , 1204 – 1208 ( 1993. ). [PubMed] [Google Scholar]
  • 21).Tanaka , T. , Konno , H. , Matsuda , I. , Nakamura , S. and Baba , S.Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP‐470 . Cancer Res. , 55 , 836 – 839 ( 1995. ). [PubMed] [Google Scholar]
  • 22).Kerr , J. F. , Wyllie , A. H. and Currie , A. R.Apoptosis: a basic biological phenomenon with wide‐ranging implications in tissue kinetics . Br. J. Cancer , 26 , 239 – 257 ( 1972. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23).Walker , N. I. , Harmon , B. V. , Gobe , G. C. and Kerr , J. F.Patterns of cell death . Methods Achiev. Exp. Pathol. , 13 , 18 – 54 ( 1988. ). [PubMed] [Google Scholar]
  • 24).Sharkey , A. M. , Charnock Jones , D. S. , Boocock , C. A. , Brown , K. D. and Smith , S. K.Expression of mRNA for vascular endothelial growth factor in human placenta . J. Reprod. Fertil. , 99 , 609 – 615 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 25).Thompson , C. B.Apoptosis in the pathogenesis and treatment of disease . Science , 267 , 1456 – 1462 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 26).Lowe , S. W. , Ruley , H. E. , Jacks , T. and Housman , D. E.p53‐dependent apoptosis modulates the cytotoxicity of anticancer agents . Cell , 74 , 957 – 967 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 27).Santana , P. , Pena , L. A. , Haimovitz Friedman , A. , Martin , S. , Green , D. , McLoughlin , M. , Cordon Cardo , C. , Schuchman , E. H. , Fuks , Z. and Kolesnick , R.Acid sphingomyelinase‐ deficient human lymphoblasts and mice are defective in radiation‐induced apoptosis . Cell , 86 , 189 – 199 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 28).Folkman , J.What is the evidence that tumors are angiogenesis dependent ? J. Natl. Cancer Inst. , 82 , 4 – 6 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 29).Sim , B. K. , O'Reilly , M. S. , Liang , H. , Fortier , A. H. , He , W. , Madsen , J. W. , Lapcevich , R. and Nacy , C. A.A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer . Cancer Res. , 57 , 1329 – 1334 ( 1997. ). [PubMed] [Google Scholar]
  • 30).Kusaka , M. , Sudo , K. , Matsutani , E. , Kozai , Y. , Marui , S. , Fujita , T. , Ingber , D. and Folkman , J.Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP‐470 (AGM‐1470) . Br. J. Cancer , 69 , 212 – 216 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31).Kumar , R. and Fidler , I. J.Angiogenic molecules and cancer metastasis . In Vivo , 12 , 27 – 34 ( 1998. ). [PubMed] [Google Scholar]
  • 32).Asano , M. , Yukita , A. , Matsumoto , T. , Kondo , S. and Suzuki , H.Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121 . Cancer Res. , 55 , 5296 – 5301 ( 1995. ). [PubMed] [Google Scholar]
  • 33).Ling , V. , Luxenberg , D. , Wang , J. , Nickbarg , E. , Leenen , P. J. , Neben , S. and Kobayashi , M.Structural identification of the hematopoietic progenitor antigen ER‐MP12 as the vascular endothelial adhesion molecule PECAM‐1 (CD31) . Eur. J. Immunol. , 27 , 509 – 514 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 34).Shimizu , S. , Eguchi , Y. , Kamiike , W. , Itoh , Y. , Hasegawa , J. , Yamabe , K. , Otsuki , Y. , Matsuda , H. and Tsujimoto , Y.Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl‐2 and Bcl‐XL . Cancer Res. , 56 , 2161 – 2166 ( 1996. ). [PubMed] [Google Scholar]
  • 35).Ikeda , H. , Suzuki , Y. , Suzuki , M. , Koike , M. , Tamura , J. , Tong , J. , Nomura , M. and Itoh , G.Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium . Gut , 42 , 530 – 537 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36).Yoshimura , S. , Banno , Y. , Nakashima , S. , Takenaka , K. , Sakai , H. , Nishimura , Y. , Sakai , N. , Shimizu , S. , Eguchi , Y. , Tsujimoto , Y. and Nozawa , Y.Ceramide formation leads to caspase‐3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl‐2 on ceramide formation and caspase‐3 activation . J. Biol. Chem. , 273 , 6921 – 6927 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 37).Vogt , M. , Bauer , M. K. , Ferrari , D. and Schulze Osthoff , K.Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO‐1/Fas) ligand expression in microglial cells . FEBS Lett. , 429 , 67 – 72 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 38).Keyt , B. A. , Nguyen , H. V. , Berleau , L. T. , Duarte , C. M. , Park , J. , Chen , H. and Ferrara , N.Identification of vascular endothelial growth factor determinants for binding KDR and FLT‐1 receptors. Generation of receptor‐selective VEGF variants by site‐directed mutagenesis . J. Biol. Chem. , 271 , 5638 – 5646 ( 1996. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES